United States · FDA National Drug Code directory

GLYCOPYRROLATE

Source ingredient · 201 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

United States · Source reference 0404-9775_6b90d651-b13c-441c-ab12-8f866f0bfcbb

Glycopyrrolate

INJECTION, SOLUTION / Henry Schein, Inc.

United States · Source reference 0404-9776_25fc7503-41ff-49f5-87d5-476fa9f279dc

Glycopyrrolate

INJECTION, SOLUTION / Henry Schein, Inc.

United States · Source reference 0404-9777_99c1e8e8-011a-455b-accb-95d07bd46c17

Glycopyrrolate

INJECTION, SOLUTION / Henry Schein, Inc.

United States · Source reference 0404-9782_f5b26115-ebee-47f8-8fc3-3d52d0695015

Glycopyrrolate

INJECTION, SOLUTION / Henry Schein, Inc.

United States · Source reference 0517-4601_717932bc-0c76-4910-8476-8d1e42b7a8fe

Glycopyrrolate

INJECTION, SOLUTION / American Regent, Inc.

United States · Source reference 0517-4602_717932bc-0c76-4910-8476-8d1e42b7a8fe

Glycopyrrolate

INJECTION, SOLUTION / American Regent, Inc.

United States · Source reference 0517-4605_717932bc-0c76-4910-8476-8d1e42b7a8fe

Glycopyrrolate

INJECTION, SOLUTION / American Regent, Inc.

United States · Source reference 0517-4620_717932bc-0c76-4910-8476-8d1e42b7a8fe

Glycopyrrolate

INJECTION, SOLUTION / American Regent, Inc.

United States · Source reference 0641-6212_9cafddcc-42f5-486b-9a17-46d75bd6227b

Glycopyrrolate

INJECTION / Hikma Pharmaceuticals USA Inc.

United States · Source reference 0641-6213_9cafddcc-42f5-486b-9a17-46d75bd6227b

Glycopyrrolate

INJECTION / Hikma Pharmaceuticals USA Inc.

United States · Source reference 0781-3825_61974545-5e98-4c25-8ce4-6b9c7fd28d40

Glycopyrrolate

INJECTION / Sandoz Inc

United States · Source reference 0781-3827_61974545-5e98-4c25-8ce4-6b9c7fd28d40

Glycopyrrolate

INJECTION / Sandoz Inc

United States · Source reference 0781-3829_61974545-5e98-4c25-8ce4-6b9c7fd28d40

Glycopyrrolate

INJECTION / Sandoz Inc

United States · Source reference 0781-3831_61974545-5e98-4c25-8ce4-6b9c7fd28d40

Glycopyrrolate

INJECTION / Sandoz Inc

United States · Source reference 0904-6709_ebc35f92-eb12-412f-93e8-ff7a9a1f73fd

Glycopyrrolate

TABLET / Major Pharmaceuticals

United States · Source reference 16571-743_9f8d9c4c-f326-4784-8ea4-f791613077f7

Glycopyrrolate

TABLET / Rising Pharma Holdings, Inc.

United States · Source reference 16571-744_9f8d9c4c-f326-4784-8ea4-f791613077f7

Glycopyrrolate

TABLET / Rising Pharma Holdings, Inc.

United States · Source reference 16729-471_415de5a5-d773-4816-e063-6294a90a6853

Glycopyrrolate

INJECTION / Accord Healthcare, Inc.,

United States · Source reference 16729-472_415de5a5-d773-4816-e063-6294a90a6853

Glycopyrrolate

INJECTION / Accord Healthcare, Inc.,

United States · Source reference 16729-473_415de5a5-d773-4816-e063-6294a90a6853

Glycopyrrolate

INJECTION / Accord Healthcare, Inc.,

United States · Source reference 16729-474_415de5a5-d773-4816-e063-6294a90a6853

Glycopyrrolate

INJECTION / Accord Healthcare, Inc.,

United States · Source reference 17856-1016_50b493e0-024d-e6ac-e063-6294a90a570d

Glycopyrrolate

SOLUTION / Atlantic Biologicals Corp.

United States · Source reference 23155-606_d512ee19-1141-4887-b0ab-123d408b5515

Glycopyrrolate

TABLET / Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

United States · Source reference 23155-607_d512ee19-1141-4887-b0ab-123d408b5515

Glycopyrrolate

TABLET / Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

United States · Source reference 25021-796_13b1a856-788d-4154-a4b5-daa5a008cafa

Glycopyrrolate

INJECTION, SOLUTION / Sagent Pharmaceuticals

United States · Source reference 31722-016_e3b10753-2b28-5dd9-e053-2995a90a8687

Glycopyrrolate

SOLUTION / Camber Pharmaceuticals, Inc.

United States · Source reference 49884-042_3492c9f9-7d9b-4943-a68c-5e269f056640

Glycopyrrolate

SOLUTION / Par Health USA, LLC

United States · Source reference 49884-065_3b3e28e1-8b2f-4947-8ca3-41b53aeade8e

Glycopyrrolate

TABLET / Par Health USA, LLC

United States · Source reference 49884-066_3b3e28e1-8b2f-4947-8ca3-41b53aeade8e

Glycopyrrolate

TABLET / Par Health USA, LLC

United States · Source reference 50268-363_2f8b2a36-ac60-7762-e063-6294a90ae573

Glycopyrrolate

TABLET / AvPAK

Browse ingredients in United States →